Covered recipient · General Payments record
MATHEW M REYNOLDS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$717.44
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $515.79 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $144.91 | 9 |
| Novo Nordisk AS | $132.72 | 10 |
| PFIZER INC. | $71.50 | 3 |
| ABBVIE INC. | $56.13 | 2 |
| ABIOMED | $42.91 | 1 |
| Acerta Pharma LLC | $35.47 | 2 |
| Astellas Pharma US Inc | $17.46 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.81 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108078758 | CMS |
| ABBVIE INC. | $31.32 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108078760 | CMS |
| ABIOMED | $42.91 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142199217 | CMS |
| Amgen Inc. | $16.95 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117665437 | CMS |
| Amgen Inc. | $14.53 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117665439 | CMS |
| Amgen Inc. | $14.29 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117363643 | CMS |
| Amgen Inc. | $26.41 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117665451 | CMS |
| Amgen Inc. | $17.52 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117665441 | CMS |
| Amgen Inc. | $16.57 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117665443 | CMS |
| Amgen Inc. | $13.65 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117665445 | CMS |
| Amgen Inc. | $15.93 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117665447 | CMS |
| Amgen Inc. | $9.06 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117665449 | CMS |
| Astellas Pharma US Inc | $17.46 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139474438 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.97 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105633966 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.50 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104529738 | CMS |
| Novo Nordisk Inc | $18.03 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100340098 | CMS |
| Novo Nordisk Inc | $11.18 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100329152 | CMS |
| Novo Nordisk Inc | $8.87 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100505021 | CMS |
| Novo Nordisk Inc | $9.15 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100247912 | CMS |
| Novo Nordisk Inc | $14.47 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100635341 | CMS |
| Novo Nordisk Inc | $17.26 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100574868 | CMS |
| Novo Nordisk Inc | $11.81 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100328932 | CMS |
| Novo Nordisk Inc | $18.52 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100236642 | CMS |
| Novo Nordisk Inc | $15.17 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100567852 | CMS |
| Novo Nordisk Inc | $8.26 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100464414 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.69 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119170810 | CMS |
| PFIZER INC. | $22.43 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131187829 | CMS |
| PFIZER INC. | $23.39 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131320897 | CMS |
| PFIZER INC. | $25.68 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131785336 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.